Home
Davipharm

Davipharm Market Share Analysis for August 2026

Relieving symptoms of increased gastric acid (sour belching, heartburn, dyspepsia). Treatment of hyperacidity in peptic ulcers (and currently there are many more effective therapies and no recurrence). Prevention and treatment of stress-related ulcer and bleeding in gastrointestinal tract Treatment of gastroesophageal refux. This is only the preview. Please check here for the full indication.

Health > Health - Other

Domaindavipharm.info

Year Founded2004

Employees201 - 500

Annual Revenue< $1M

Davipharm

Davipharm (including company regionals)

davipharm.info

See more website traffic and engagement information

Total visits to Davipharm's top domains

Understand Davipharm market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

davipharm.info6.1K

See more with Sales Intelligence

Avg. visit duration in Davipharm's top domains

Analyze Davipharm engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

davipharm.info00:00:33

See more with Sales Intelligence

Avg. pageviews on Davipharm's top domains

See how Davipharm keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

davipharm.info2.57

See more with Sales Intelligence

Davipharm top competitors by domain

Top similar sites in August 2026, ranked by their affinity

glandpharma.comCompany NameGland PharmaEmployees1001 - 5000HQIndia, Airforce AcademyAnnual revenue> $1BTotal visits12.4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Davipharm

These are the website technologies, by industry, used by Davipharm top domains

Widget (6)

Twemoji

Payment & Currencies (4)

Cart Functionality

Advertising (3)

PubMatic

Conversion & Analytics (3)

Google Analytics

More Technologies

8

See all

News & Signals from Davipharm

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDavipharm invests into assets: R&D equipment and laboratory in the amount of $3.5M in Vietnam, South-eastern Asia, Asia.To support future innovation, Davipharm invested almost USD 3.5 million in R&D equipment and laboratory renovation, creating a safer, more modern working environment while strengthening research capabilities for increasingly complex pharmaceutical products.